Abstract:Background Ulcerative colitis (UC) is an inflammatory bowel disease characterized by idiopathic and recurrent mucosal inflammation [1]. The pathogenesis is multifactorial, involving genetic susceptibility, epithelial barrier defects, dysregulation of the immune response, and environmental factors. UC is a highly heterogeneous disease [2]. Despite efforts to characterize disease subgroups and predict differential outcomes in UC patients, disease heterogeneity is not adequately translated into current clinical subclassifications. Objectives This study seeks to unravel this complexity by using an integrated systems approach that classifies UC patients into different phenotypes based on the immune microenvironment, capable of providing new insights into the development of stratified therapies. Methods RNA sequencing datasets of 602 colon tissue samples from 455 patients with UC and 147 healthy controls (HC) was imported from GEO database. The microarray datasets were transformed into immune cell components by CIBERSORT, and patients were stratified by a consensus clustering algorithm. Then, the cellular characteristics of the subtypes and the overall role of specific pathways were determined by immune cell infiltration and pathway enrichment. The clinical characteristics of the different subtypes were also analyzed to clarify the characteristics of these classifications. Results Patients can be classified into two distinct immune phenotypes (Subtype A, B) based on their specific RIME, which have different cellular and pathway characteristics. (Figure A, B) The results show that Subtype A is mainly enriched in immune cells such as B cells, CD8+ T cells, CD4+ memory T cells, DC cells, macrophages, mast cells and plasma cells. Acidic granulocytes and neutrophils were more active in Subtype B. It was also significantly enriched in the peroxisome proliferator-activated receptor (PPAR) signaling pathway in Subtype B. In contrast, Subtype A showed a strong enrichment for most inflammatory pathways B cell and T cell receptor signaling, IL-17 signaling pathway, TNF, and interleukin 4 and interleukin 13 signaling pathway. (Figure 1 D, E) In addition, there was a significant difference between molecular subclassification and disease status, with Subtype A being more active in patients (69.3% of Subtype A vs.30.6% of Subtype B subtypes in 137 cases), while inactive patients, Subtype B were more prevalent (44.8% of Subtype A vs. 55.2% of Subtype B in 105 cases). (Figure 1C) Conclusion Analysis of the immune microenvironment of colonic mucosal tissue provides good insight into the pathophysiological characteristics of UC. These results can be used as a model for future studies. the response and clinical outcomes of patients with different classification need to be further investigated. References [1]Ghosh S, Shand A, Ferguson A. Ulcerative colitis. BMJ (Clinical research ed). 2000;320(7242):1119-23. [2]Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet (London, England). 2012;380(9853):1606-19. Acknowledgements: NIL. Disclosure of Interests None Declared.

Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses

Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease

Mass Cytometry and Single-Cell Transcriptome Analyses Reveal the Immune Cell Characteristics of Ulcerative Colitis

Identification of ulcerative colitis-specific immune cell signatures from public single-cell RNA-seq data

Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases

Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans

P018 Myeloid diversity in inflammatory bowel disease revealed by single-cell transcriptomics

A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn’s Disease

Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients

A novel unconventional T cell population enriched in Crohn's disease

Single-Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells From Ulcerative Colitis Patients

Single-cell analysis of Crohn's disease: Unveiling heterogeneity and evaluating ustekinumab outcomes

Single-Cell RNA-Sequencing Analysis of Colonic Lamina Propria Immune Cells Reveals the Key Immune Cell-Related Genes of Ulcerative Colitis

Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy

Colonic epithelial cell diversity in health and inflammatory bowel disease

The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon

Landscape of Cell Heterogeneity and Evolutionary Trajectory in Ulcerative Colitis-associated Colon Cancer Revealed by Single-cell Rna Sequencing

Single-cell analysis of colonic epithelium reveals unexpected shifts in cellular composition and molecular phenotype in treatment-naïve adult Crohn’s disease

AB1675 DEEP PHENOTYPING OF IMMUNE MICROENVIRONMENT IN ULCERATIVE COLITIS BY INTEGRATIVE SYSTEMS ANALYSIS

Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn's disease

P015 CITE-seq analysis revealed immune cell diversity in colonic mesenteric lymph nodes from IBD patients